Partner at Williams & Connolly LLP
Dov Grossman is an accomplished trial lawyer with over 15 years of experience litigating biopharmaceutical patent disputes, including as lead counsel. Mr Grossman’s educational background is in chemistry – with an emphasis on medicinal chemistry – and he has relied on that experience to successfully represent some of the world’s largest innovator pharmaceutical companies in a wide variety of patent disputes, including for multiple billion-dollar products. Mr Grossman has extensive experience litigating Hatch-Waxman cases, both in the district courts and on appeal. He has also litigated brand v brand patent disputes between innovator companies and has handled numerous inter partes review proceedings before the PTAB.
In addition to pharmaceutical-related matters, Mr Grossman has litigated patent cases in the medical device and telecommunications industries. He also has advised clients on the negotiation of patent licensing agreements, including as the lead outside attorney handling the negotiations.
Mr Grossman earned his JD, with honours, from the University of Chicago, where he was articles editor for The University of Chicago Law Review and a member of the Order of the Coif. He clerked for Judge William C Bryson of the US Court of Appeals for the Federal Circuit. He received his AB in chemistry, magna cum laude, from Harvard University in 1997, and an MSc in chemistry from the Weizmann Institute of Science in 1999. Aspects of his Weizmann research were published in Letters in Peptide Science in 2002 (“Potentiating Vanadium-Evoked Glucose Metabolism by Novel Hydroxamate Derivatives”).